Login / Signup

Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital.

Niamh CunninghamScott ShepherdKabir MohammedKarla A LeeMark AllenStephen JohnstonEmma KippsSophie McGrathJillian NobleMarina PartonAlistair RingNicholas C TurnerAlicia F C Okines
Published in: Breast cancer research and treatment (2022)
Neratinib monotherapy or in combination with capecitabine is a useful treatment for patients with and without brain metastases. PFS and OS were found to be similar as previous trial data. Routine anti-diarrhoeal prophylaxis allows this combination to be safely delivered to patients in a real-world setting.
Keyphrases